A Phase I Study of PCUR-101 in Combination With Androgen Suppression Therapy in the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer
Clinical trial NCT03137758 · TERMINATED
Trial details
- NCT number
- NCT03137758
- Sponsor
- Pellficure Pharmaceuticals, Inc
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-24
- Primary completion
- 2019-04-03
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.